Batavia Biosciences BV

Leiden, Zuid-Holland, Netherlands


Purpose

To accelerate development of low-cost, liquid RV3-BB rotavirus vaccine at BioFarma for use in Indonesian public markets and Gavi countries through formulation development and bulk process optimization

Division

Global Health

Date

June 2016

Region Served

GLOBAL

Committed amount

$6,480,214

Grant topic

Enteric and Diarrheal Diseases

Duration (months)

48

Grantee location

Leiden, Zuid-Holland, Netherlands

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.